Propofol and remifentanil effect-site concentrations estimated by pharmacokinetic simulation and bispectral index monitoring during craniotomy with intraoperative awakening for brain tumor resection

Journal of Neurosurgical Anesthesiology

Volumn 19, Issue 3, 2007, Pages 183-189

  Lobo, Francisco ^a   Beiras, Aldara ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Awake craniotomy; Pharmacokinetic simulation; Propofol; Remifentanil

Indexed keywords

MIDAZOLAM; PROPOFOL; REMIFENTANIL;

ADULT; AROUSAL; ARTICLE; BISPECTRAL INDEX; BRAIN TUMOR; CANCER SURGERY; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOTOMY; DRUG EFFECT; HUMAN; MULTIPLE REGRESSION; NEUROLOGIC EXAMINATION; PATIENT MONITORING; PRIORITY JOURNAL; SIMULATION; SLEEP WAKING CYCLE;

ADULT; ANESTHESIA, GENERAL; ANESTHETICS, COMBINED; ANESTHETICS, INTRAVENOUS; BRAIN NEOPLASMS; COMPUTER SIMULATION; CONSCIOUS SEDATION; CRANIOTOMY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LARYNGEAL MASKS; MALE; MONITORING, INTRAOPERATIVE; PIPERIDINES; PREDICTIVE VALUE OF TESTS; PROPOFOL; RETROSPECTIVE STUDIES; WAKEFULNESS;

EID: 34347341679     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31805f66ad     Document Type: Article

References (40)

1. Keifer JC, Dentchev D, Little K, et al. A retrospective analysis of a remifentanil/propofol general anesthetic for craniotomy before awake functional brain mapping. Anesth Analg. 2005;101:502-508.
2. Whittle IR, Migdley S, Georges H, et al. Patient perceptions of "awake" brain tumor surgery. Acta Neurochir(Wien). 2005;147:275-277.
3. Ard JL, Bekker AY, Doyle WK. Dexmedetomidine in awake craniotomy: a technical note. Surg Neurol. 2005;63:114-117.
4. Audu PB, Loomba N. Use of cuffed oropharyngeal airway for awake intracranial surgery. J Neurosurg Anesthesiol. 2004;16:144-146.
5. Costello TG, Cormack JR. Anesthesia for awake craniotomy: a modern approach. J Clin Neurosci. 2004;11:16-19.
6. Yamamoto F, Kato R, Sato J, et al. Anesthesia for awake craniotomy with non-invasive positive pressure ventilation. Br J Anaesth. 2003;90:382-385.
7. Sarang A, Dinsmore J. Anaesthesia for awake craniotomy - evolution of a technique that facilitates awake neurological testing. Br J Anaesth. 2003;90:161-165.
8. Tijero T, Ingelmo I, Garcia-Trapero J, et al. Usefulness of monitoring brain tissue oxygen pressure during awake craniotomy for tumor resection: a case report. J Neurosurg Anesthesiol. 2002;14:149-152.
9. Berkenstadt H, Perel A, Hadani M, et al. Monitored anesthesia care using remifentanil and propofol for awake craniotomy. J Neurosurg Anesthesiol. 2001;13:246-249.
10. Fukuya C, Katayama Y, Yoshino A, et al. Intraoperative wake-up procedure with propofol and laryngeal mask for optimal excision of brain tumor in eloquent areas. J Clin Neurosci. 2001;8:253-255.
11. Tongier WK, Joshi GP, Landers DF, et al. Use of laryngeal mask during awake craniotomy for tumor resection. J Clin Anesth. 2000;12:592-594.
12. Hans P, Bonhomme V, Born JD, et al. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anaesthesia. 2000;55:255-259.
13. Huncke K, Van de Wiele B, Fried I, et al. The asleep-awake-asleep anesthetic technique for intraoperative language mapping. Neurosurgery. 1998;42:1312-1316.
14. Johnson KB, Egan TD. Remifentanil and propofol combination for awake craniotomy: case report with pharmacokinetic simulations. J Neurosurg Anesthesiol. 1998;10:25-29.
15. Picht T, Kombos T, Gramm HJ, et al. Multimodal protocol for awake craniotomy in language cortex tumor surgery. Acta Neurochir (Wien). 2006;148:127-138.
16. Bonhomme V, Born JD, Hans P. Anaesthetic management of awake craniotomy. Ann Fr Anesth Reanim. 2004;23:389-394.
17. Sheiner LB, Stanski DR, Vozeh S et al. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d-tubocuranine. Clin Pharm Ther. 1979;25:358-571.
18. Wakeling HG, Zimmerman JB, Howell S, et al. Targeting effect-site compartment or central compartment concentration of propofol: what predicts loss of consciousness? Anesthesiology. 1999;90:92-97.
19. Schnider TW, Minto CF, Gambus P, et al. The influence of method of administration and covariances on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998;88:1170-1182.
20. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology. 1999;90:1502-1516.
21. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86:10-23.
22. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997;86:24-33.
23. Fabregas N, Rapado J, Gambus PL, et al. Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery. Anesthesiology. 2002;97:1378-1386.
24. Ferreira DA, Nunes CS, Antunes L, et al. Practical aspects of the use of target controlled infusion with remifentanil in neurosurgical patients: predicted cerebral concentrations at intubation, incision and extubation. Acta Anaesth Belg. 2006;57:265-270.
25. Costello TG, Cormack JR, Hoy C, et al. Plasma Ropivacaine levels following scalp block for awake craniotomy. J Neurosurg Anesthesiol. 2004;16:147-150.
26. Lobo FA, Amorim P. Anesthesia for craniotomy with intraoperative awakening: how to avoid respiratory depression and hypertension? Anesth Analg. 2006;102:1593-1594.
27. Lee MPL, Kua JSW, Chiu WKY. The use of remifentanil to facilitate the insertion of the laryngeal mask airway. Anesth Analg. 2001;93:359-362.
28. Gepts E, Jonckheer K, Maes V, et al. Disposition kinetics of propofol during alfentanil anaesthesia. Anaesthesia. 1988;43(suppl):8-13.
29. Dyck JB, Shafer SL. Effects of age on propofol pharmacokinetics. Semin Anesth. 1992;11:2-4.
30. Milne SE, Kenny GN, Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth. 2003;90:623-629.
31. Kern SE, Xie G, White JL. Opioid-hypnotic synergy. A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers. Anesthesiology. 2004;100:1373-1381.
32. Iwakiri H, Nishihara N, Nagata O, et al. Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening. Anesth Analg. 2005;100:107-110.
33. Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth. 1991;67:41-48.
34. Lobo F, Beiras A, Armas M, et al. Remifentanil infusion during propofol anesthesia maintained throughout recovery does not delay emergence and extubation. J Neurosurg Anesthesiol. 2004;16:362-363.
35. Gan TJ, Glass PS, Windsor A. Bispectral index monitoring allow faster emergence and improved recovery from propofol, alfentanil and nitrous oxide anesthesia. Anesthesiology. 1997;87:808-815.
36. Syroid ND, Agutter J, Drews FA, et al. Development and evaluation of a graphical anesthesia drug display. Anesthesiology. 2002;96:565-575.
37. Billard V, Deleuze A, Penot C, et al. Sufentanil in balanced anesthesia: need to predict concentrations for dose optimization. Ann Fr Anesth Reanim. 1999;18:237-242.
38. Gambus P, Schnider TW, Minto CF. Characterization of dose profile of remifentanil with computer simulation: comparative study with fentanyl and alfentanyl. Rev Esp Anestesiol Reanim. 1998;45:317-325.
39. Egan TD. Target-controlled drug delivery. Progress toward an intravenous "vaporizer" and automated anesthesia administration. Anesthesiology. 2003;99:1214-1219.
40. Egan TD, Shafer SL. Target-controlled infusions for intravenous anesthetics. Surfing USA not! Anesthesiology. 2003;99:1039-1041.